Hyperglycemia-induced placental inflammation involves differential activation of RAGE-associated PI3K/MAPK/NF-κB signaling pathways
9 affiliations
- 1Departamento de Inmunobioquímica, Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Mexico City, Mexico
- 2Posgrado en Ciencias Biológicas, Universidad Nacional Autónoma de México, Mexico City, Mexico
- 3Departamento de Biología de la Reproducción Dr. Carlos Gual Castro, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
- 4Unidad de Investigación Médica en Medicina Reproductiva, UMAE, Hospital de Gineco-Obstetricia no. 4 “Luis Castelazo Ayala”, Instituto Mexicano del Seguro Social, Mexico City, Mexico
- 5SECIHTI- Hospital Infantil de México Federico Gómez, Mexico City, Mexico
- 6Subdirección de Investigación Biomédica, Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Mexico City, Mexico
- 7Departamento de Ginecología y Obstetricia, Hospital Ángeles México, Mexico City, Mexico
- 8Ginecología y Obstetricia, Hospital Ángeles Lomas – UNAM, Huixquilucan, Mexico
- 9Dirección de Investigación, Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Mexico City, Mexico
Abstract
Background: Exposure to elevated glucose levels during intrauterine life is detrimental to both the mother and fetus. As a glucose-sensitive organ, the placenta responds to hyperglycemia by mounting a pro-inflammatory response characterized by increased production of inflammatory mediators that disrupt the immune privilege of the maternal-fetal interface. Although hyperglycemia promotes inflammation in human placental tissue, the molecular mechanisms through which HMGB1 release and advanced glycation end products (AGEs) accumulation converge on RAGE-associated signaling pathways to sustain this response remain poorly understood.
Objective: To investigate the molecular mechanisms by which hyperglycemia activates HMGB1/AGEs-dependent signaling networks leading to inflammatory responses in human placental villi.
Methods: Human term placental villous explants were exposed to normal or high glucose concentrations for 1–9 h or 48 h. For pathway inhibition experiments, explants were treated with selective inhibitors during high-glucose exposure. Inflammatory mediators, extracellular HMGB1, glyoxal-derived AGEs, TLR4 and RAGE expression, and activation of Akt1, ERK1/2, and NF-κB were evaluated.
Results: High-glucose exposure elicited a pro-inflammatory phenotype characterized by increased extracellular HMGB1 release, enhanced glyoxal-derived AGEs formation, and elevated TLR4 expression, supporting the involvement of HMGB1/AGE-RAGE signaling. Mechanistically, hyperglycemia was associated with activation of the PI3K/Akt and MAPK/ERK1/2 pathways, promoting NF-κB activation, suggesting the participation of both RAGE-dependent and RAGE-independent mechanisms, leading to increased secretion of TNF-α, IL-1β, and IL-6. Pharmacological inhibition experiments suggested the existence of putative interconnected positive feedback loops linking AGE accumulation, HMGB1 release, RAGE activation, and downstream inflammatory signaling, supporting the establishment of a self-sustaining metainflammatory network in placental villi.
Conclusions: Collectively, these findings provide insight into the mechanisms by which sustained maternal hyperglycemia reshapes placental immune signaling and promotes a chronic metainflammatory state that may compromise placental function. Our results support a mechanistic model in which HMGB1/AGE-RAGE/TLR4 signaling contributes to placental dysfunction during gestational hyperglycemia.
Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s10020-026-01604-3.
Related
- Early diagnosis of capivasertib-associated severe hyperglycemia with diabetic ketosis diagnosed in routine clinical practice: a case report with review of literature
- Hyperglycemia-Induced Loss of Astrocytic Kir4.1 Is Associated with Increased DNMT1 Activity and Altered AMPK/SIRT1 Signaling
- Progression of Chronic Liver Inflammation and Fibrosis Driven by Activation of c-JUN Signaling in Sirt6 Mutant Mice
- Metabolomics identifies endocannabinoid system remodeling during obesity associated inflammation in adipose tissue
- Optimized Super-SILAC Normalization Enables Enhanced Profiling of Histone Post-Translational Modification Changes Associated with Microbiota and Acute Inflammation
BibTeX
@article{vargasalcantar2026hyperglycemiainduced,
title = {{Hyperglycemia-induced placental inflammation involves differential activation of RAGE-associated PI3K/MAPK/NF-κB signaling pathways}},
author = {Donovan Vargas-Alcantar and Karina Martínez-Garfias and Karla Hernández-Bones and Rodrigo Jiménez-Escutia and Samara Rodríguez-Flores and Eulises Díaz-Díaz and Aleida Olivares and Lourdes Alvarez-Arellano and Consuelo Lomas-Soria and Ismael Mancilla-Herrera and Pilar Velázquez-Sánchez and Rodrigo Zamora-Escudero and Paloma Cervantes-Delgado and Lorenza Díaz and Verónica Zaga-Clavellina and Andrea Olmos-Ortiz},
journal = {Molecular Medicine},
year = {2026},
month = aug,
doi = {10.1186/s10020-026-01604-3},
url = {https://doi.org/10.1186/s10020-026-01604-3},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Hyperglycemia-induced placental inflammation involves differential activation of RAGE-associated PI3K/MAPK/NF-κB signaling pathways
AU - Donovan Vargas-Alcantar
AU - Karina Martínez-Garfias
AU - Karla Hernández-Bones
AU - Rodrigo Jiménez-Escutia
AU - Samara Rodríguez-Flores
AU - Eulises Díaz-Díaz
AU - Aleida Olivares
AU - Lourdes Alvarez-Arellano
AU - Consuelo Lomas-Soria
AU - Ismael Mancilla-Herrera
AU - Pilar Velázquez-Sánchez
AU - Rodrigo Zamora-Escudero
AU - Paloma Cervantes-Delgado
AU - Lorenza Díaz
AU - Verónica Zaga-Clavellina
AU - Andrea Olmos-Ortiz
PY - 2026
DA - 2026/08/01
JO - Molecular Medicine
DO - 10.1186/s10020-026-01604-3
UR - https://doi.org/10.1186/s10020-026-01604-3
AB - Background: Exposure to elevated glucose levels during intrauterine life is detrimental to both the mother and fetus. As a glucose-sensitive organ, the placenta responds to hyperglycemia by mounting a pro-inflammatory response characterized by increased production of inflammatory mediators that disrupt the immune privilege of the maternal-fetal interface. Although hyperglycemia promotes inflammation in human placental tissue, the molecular mechanisms through which HMGB1 release and advanced glycation end products (AGEs) accumulation converge on RAGE-associated signaling pathways to sustain this response remain poorly understood. Objective: To investigate the molecular mechanisms by which hyperglycemia activates HMGB1/AGEs-dependent signaling networks leading to inflammatory responses in human placental villi. Methods: Human term placental villous explants were exposed to normal or high glucose concentrations for 1–9 h or 48 h. For pathway inhibition experiments, explants were treated with selective inhibitors during high-glucose exposure. Inflammatory mediators, extracellular HMGB1, glyoxal-derived AGEs, TLR4 and RAGE expression, and activation of Akt1, ERK1/2, and NF-κB were evaluated. Results: High-glucose exposure elicited a pro-inflammatory phenotype characterized by increased extracellular HMGB1 release, enhanced glyoxal-derived AGEs formation, and elevated TLR4 expression, supporting the involvement of HMGB1/AGE-RAGE signaling. Mechanistically, hyperglycemia was associated with activation of the PI3K/Akt and MAPK/ERK1/2 pathways, promoting NF-κB activation, suggesting the participation of both RAGE-dependent and RAGE-independent mechanisms, leading to increased secretion of TNF-α, IL-1β, and IL-6. Pharmacological inhibition experiments suggested the existence of putative interconnected positive feedback loops linking AGE accumulation, HMGB1 release, RAGE activation, and downstream inflammatory signaling, supporting the establishment of a self-sustaining metainflammatory network in placental villi. Conclusions: Collectively, these findings provide insight into the mechanisms by which sustained maternal hyperglycemia reshapes placental immune signaling and promotes a chronic metainflammatory state that may compromise placental function. Our results support a mechanistic model in which HMGB1/AGE-RAGE/TLR4 signaling contributes to placental dysfunction during gestational hyperglycemia. Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s10020-026-01604-3.
SN - 1076-1551
SN - 1528-3658
ER -